MedPath

The Radiation Oncology Registry and Biosample Repository

Recruiting
Conditions
Neoplasia
Registration Number
NCT01577251
Lead Sponsor
Abramson Cancer Center at Penn Medicine
Brief Summary

The goal of this study is to establish a registry and biosample repository (defined as blood, urine, and tumor specimens) in patients with a cancer and/or benign tumor diagnosis undergoing radiotherapy.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
8000
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Health Assessments10 years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (4)

Virtua Samson Cancer Center

🇺🇸

Moorestown, New Jersey, United States

Virtua Health & Wellness Center

🇺🇸

Voorhees, New Jersey, United States

Lancaster General Hospital

🇺🇸

Lancaster, Pennsylvania, United States

University of Pennsylvania

🇺🇸

Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath